Overall rank by patents
#7,049
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
NEUBORON MEDTECH LTD.
USPTO PatentsView assignee record — 47 granted patents across 21 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
47
Total patents granted
21
CPC technology areas
16.1
Avg claims per patent
+322%
5-year filing velocity
Portfolio overview
NEUBORON MEDTECH LTD. has been granted 47 US utility patents between 2018 and 2025, placing NEUBORON MEDTECH LTD. at rank #7,049 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, NEUBORON MEDTECH LTD. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 43.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 38 grants, compared with 9 in the 2015–2019 window — a +322% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. NEUBORON MEDTECH LTD.'s 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark NEUBORON MEDTECH LTD. against peers pursuing similar technology classes.
How does NEUBORON compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Neuboron Medtech ◀ 47
NEUBORON MEDTECH LTD.
47 patents
What this shows NEUBORON holds 47 patents — placing it at rank #7,049 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2018–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 4 | 8.5% |
| 2019 | 5 | 10.6% |
| 2020 | 12 | 25.5% |
| 2021 | 8 | 17.0% |
| 2022 | 6 | 12.8% |
| 2023 | 8 | 17.0% |
| 2024 | 2 | 4.3% |
| 2025 | 2 | 4.3% |
Which technologies does NEUBORON MEDTECH LTD. patent most?
Top 15 of 21 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does NEUBORON MEDTECH LTD. hold?
NEUBORON MEDTECH LTD. holds 47 US granted patents filed between 2018 and 2025, spanning 21 technology areas.
What is NEUBORON MEDTECH LTD.'s Innovation Score?
NEUBORON MEDTECH LTD. has an Innovation Score of 43.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does NEUBORON MEDTECH LTD. focus on?
NEUBORON MEDTECH LTD.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 42 patents. The company has filed patents in 21 CPC subclasses total.
Is NEUBORON MEDTECH LTD.'s patent filing rate increasing or decreasing?
NEUBORON MEDTECH LTD.'s recent filing velocity is +322% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for NEUBORON MEDTECH LTD.'s patents?
NEUBORON MEDTECH LTD.'s patents average 16.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the NEUBORON MEDTECH LTD. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61N technology
NEUBORON MEDTECH LTD.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where NEUBORON MEDTECH LTD. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
